WebCytophil, Inc. was founded in 2005 with the purpose of developing implantable medical devices to either out-license; manufacture and/or custom manufacture medical device technology. The company is located at 2485 Corporate Circle, Suite 2, East Troy, WI 53120. Cyto Contact Who is Cytophil Headquarters WebCYTOPHIL INC: 2485 CORPORATE CIRCLE: UNIT 2: EAST TROY, WI 53120 Correspondent Contact: VICTOR M BOWERS: Regulation Number: 872.3930: Classification Product Code: LYC : Date Received: 12/17/2009: Decision Date: 04/22/2010: Decision: Substantially Equivalent (SESE) Regulation Medical Specialty:
Cytophil, Inc. East Troy WI - Facebook
WebApr 6, 2016 · The case is captioned as Cytophil, Inc. v. Merz North America, Inc. and Merz Pharma GmbH & Co. KGaA, Civ. No. 2:16-cv-00423 in the United States District Court for the Eastern District of ... WebCytophil, Inc. • Manufacturing Solutions for Regenerative Medicine See What We Can Offer You Check out our products and contract services. We also use different external services like Google Webfonts, Google Maps, and … Cytophil, Inc. was founded in 2005 by Dr. William “Bill” Hubbard with the mission … Contact Cytophil, Inc. by email: [email protected] or calling toll free: +1 855-433 … Cytophil customizes the services we offer to meet your development and marketing … Please contact us to discuss your specific medical device commercialization … Renú® calcium hydroxylapatite (CaHA) implant is indicated as a soft tissue … Renú® CE is an injectable calcium hydroxylapatite (CaHA) implant that is … Orthopedic ß-TCP: Nonallograft Osteoconductive Bone Graft … Renú® Voice is a buffered hydrogel containing synthetic Calcium … hockey collective
Dermal Filler Market revenue to cross USD 9.4 Bn by 2028:
WebJan 11, 2012 · Periophil Biphasic (synthetic grafting material) is intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects. Cytophil, Inc., 2485 Corporate Circle, Suite 2, East Roy, WI 53120. Code Information: 1. 03001-02 Periophil Biphasic, Lot # Z13-927A, expiration date 2/1/2014. 2. WebDec 16, 2015 · REGENSCIENTIFIC, a wholly-owned business unit of Cytophil, Inc., an ISO 13485 certified company, is dedicated to providing physicians and patients with high-quality, safe, efficacious, and cost ... WebApr 10, 2024 · WASHINGTON, April 10, 2024 (GLOBE NEWSWIRE) -- The Global Dermal Fillers Market was valued at USD 4.36 Billion in the year 2024 and is projected to reach a value of USD 8.75 Billion by the year 2030. htaccess for laravel